Corey Hobbs, MD
Radiation Oncology · Jacksonville, FLNPI 1336433770
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Novartis at 27.5% of the total. 2025 is the largest year on record at $294, 2.5 times the $119 reported in 2019. That places this record below the midpoint for radiation oncology clinicians in FL, where the typical reported total is $724.
Across 20 payments — averaging $35.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$194
- Novocure Inc.$147
- Merck$119
- Progenics Pharmaceuticals, Inc.$115
- Gilead$23
- Sun Pharmaceutical Industries Inc.$20
- plus $86 from 5 others
What the payments were for
- Food & beverage$704100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 10 | $194 |
| Novocure Inc. | 1 | $147 |
| Merck | 1 | $119 |
| Progenics Pharmaceuticals, Inc. | 1 | $115 |
| Gilead | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Myovant Sciences Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optune Gio$147
- ZERBAXA$119
- PYLARIFY$115
How this compares
$704 in reported general payments places this provider in the 45th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 15 | $540 |
| Dexamethasone | 17 | $302 |
| Tamsulosin Hcl | 15 | $140 |
| Omeprazole | 11 | $110 |
| Ondansetron Hcl | 18 | $93 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Jacksonville
- Daniel TrifilettiJacksonville$24K
- Bradford HoppeJacksonville$11K
- Scot AckermanJacksonville$8K
- Shravan KandulaOrlando$444K
- Martin KeischMiami Shores$319K
- Marcio FagundesMiami$274K
- Evan ThomasWinter Park$209K
- Rupesh KotechaMiami$208K
- John SylvesterLakewood Ranch$205K
- Ravi ShridharOrlando$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.